Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05350865

Thailand HDV Cohort

Sponsor: The HIV Netherlands Australia Thailand Research Collaboration

View on ClinicalTrials.gov

Summary

There is very limited data of HDV in Thailand. As both HDV and HIV can accelerate the HBV course and increased the risk of death, particularly, among those with low CD4 cells/count, therefore, HDV burden in this special population is unmet need. Therefore, this study plans to perform a nationwide survey of the prevalence and predictor of HDV among people uses drugs (PWID) with and without HIV, HBV/HIV (MSM vs non MSM), HBV related cirrhosis. Findinds from this study will provide the scientific community to understand how important HDV is among HBV patients, this could be used to develop strategies for HDV screening and treatment

Official title: Prevalence, Risk Factor and Clinical Significance of Hepatitis D Virus Infection Among Targeted High Risk Population in Thailand: Nationwide Survey 2022-2024

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

3152

Start Date

2023-01-30

Completion Date

2025-05

Last Updated

2024-10-02

Healthy Volunteers

No

Conditions

Locations (4)

HIV-NAT, Thai Red Cross - AIDS Research Centre

Bangkok, Bangkok, Thailand

King memorial Chulalongkorn hospital

Bangkok, Bangkok, Thailand

Siriraj Hospital, Mahidol University

Bangkok, Bangkok, Thailand

Taksin Hospital

Bangkok, Bangkok, Thailand